Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Stada Generics Takes A Hit Even As Firm Steals A March On Rivals
Group’s Sales ‘Better Than The Average For The Top-Five Suppliers’
Sep 02 2021
•
By
Dean Rudge
Stada Generics adjusted EBITDA fell by 12% • Source: Alamy
More from Biosimilars
More from Products